Thoracic Cancer

Papers
(The H4-Index of Thoracic Cancer is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Issue Information203
Issue Information61
Issue Information54
Issue Information41
Issue Information37
Pathological characteristics of lung tumors in Sri Lanka 2017–202135
Salidroside suppresses the multiple oncogenic activates and immune escape of lung adenocarcinoma through the circ_0009624‐mediated PD‐L1 pathway34
Identification of predictive factors for early relapse in patients with unresectable stage III non‐small cell lung cancer receiving consolidation durvalumab after concurrent chemoradiation 34
Multi‐center experience in an optimized right upper lobectomy surgical procedure in China30
A case of eosinophilic bronchiolitis after the initiation of immune checkpoint inhibitor30
Thoracic skeletal muscle mass predicts mortality in patients with surgery for pleural empyema: A case control study29
PRPS2‐mediated modulation of the antitumor immune response in lung cancer through CCL2‐mediated tumor‐associated macrophages and myeloid‐derived suppressor cells28
Neuroendocrine tumor secondary to pulmonary hypoplasia: A case report27
Diabetic ketoacidosis shortly after COVID‐19 vaccination in a non–small‐cell lung cancer patient receiving combination of PD‐1 and CTLA‐4 inhibitors: A case report26
Response to ALK‐TKIs in a lung adenocarcinoma patient harboring dual DCTN1‐ALK and ALK‐CLIP4 rearrangements26
PET–CT for visualizing the pathophysiology of COPD in patients with early‐stage NSCLC26
Angiosarcoma of breast and chest wall complicated with tuberculous empyema: A case report24
Relationship between the severity of emphysematous change in the lung and morbidity after esophagectomy for esophageal cancer: A retrospective study on a novel strategy for risk prediction23
Long‐term follow‐up of unresectable adenoid cystic carcinoma of the trachea and bronchus treated with high‐dose proton beam therapy: A report of two cases23
Evaluation of the inhibitory effect of azoles on pharmacokinetics of lenvatinib in rats both in vivo and in vitro by UPLC‐MS/MS23
Safety and efficacy of amrubicin with primary prophylactic pegfilgrastim as second‐line chemotherapy in patients with small cell lung cancer23
Secular trends of morbidity and mortality of thyroid cancer in five Asian countries from 1990 to 2019 and their predictions to 203523
Enhancing precision in lung tumor ablation through innovations in CT‐guided technique and angle control22
Rapid and reliable collection of tumor tissue for successful gene panel in a patient with advanced stage lung cancer: A case report22
Comparison of Early Functional Recovery Following Triportal Robot‐Assisted and Uniportal Video‐Assisted Segmentectomy in Patients With Early‐Stage Non‐Small Cell Lung Cancer: A Propensity Score‐Matche22
0.071927070617676